Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) FCF Margin: 2022-2025

Historic FCF Margin for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to 157.14%.

  • InMed Pharmaceuticals' FCF Margin rose 93.00% to 143.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 157.31%, marking a year-over-year decrease of 2348.00%. This contributed to the annual value of 157.14% for FY2025, which is 500.00% down from last year.
  • According to the latest figures from FY2025, InMed Pharmaceuticals' FCF Margin is 157.14%, which was down 3.29% from 152.14% recorded in FY2024.
  • In the past 5 years, InMed Pharmaceuticals' FCF Margin registered a high of 152.14% during FY2024, and its lowest value of 1,434.03% during FY2022.
  • Moreover, its 3-year median value for FCF Margin was 157.14% (2025), whereas its average is 163.09%.
  • In the last 5 years, InMed Pharmaceuticals' FCF Margin soared by 125,405bps in 2023 and then plummeted by 500bps in 2025.
  • InMed Pharmaceuticals' FCF Margin (MRY) stood at 1,434.03% in 2022, then skyrocketed by 87bps to 179.98% in 2023, then grew by 15bps to 152.14% in 2024, then dropped by 3bps to 157.14% in 2025.
  • Its last three reported values are 157.14% in FY2025, 152.14% for FY2024, and 179.98% during FY2023.